Does Rallies show Form 4 insider transactions for CCAP?

Yes. Rallies tracks CCAP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CCAP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CCAP. It does not provide personalized investment advice.

CCAP (Crescent Capital BDC, Inc. Common stock) Stock Analysis - Insider Trades

Crescent Capital BDC, Inc. Common stock (CCAP) is a publicly traded Financial Services sector company. As of May 21, 2026, CCAP trades at $11.35 with a market cap of $408.25M and a P/E ratio of 6.28. CCAP moved +0.80% today. Year to date, CCAP is -22.18%; over the trailing twelve months it is -28.48%. Its 52-week range spans $10.92 to $20.19. Analyst consensus is buy with an average price target of $14.30. Rallies surfaces CCAP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CCAP stock inside the company?

Recent CCAP insider activity includes Strandberg Steven F. bought 85.00K, Lombard Gerhard bought 2.00K, Bouek Kirill bought 200, Barrios Raymond bought 2.23K, and Barrios Raymond bought 1.01K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CCAP Key Metrics

Key financial metrics for CCAP
Metric	Value
Price	$11.35
Market Cap	$408.25M
P/E Ratio	6.28
EPS	$1.78
Dividend Yield	0.03%
52-Week High	$20.19
52-Week Low	$10.92
Volume	1.10K
Avg Volume	0
Revenue (TTM)	$65.79M
Net Income	$15.09M
Gross Margin	0.00%

Recent CCAP Insider Trades

Strandberg Steven F. bought 85.00K (~$958.49K) on May 19, 2026.
Lombard Gerhard bought 2.00K (~$26.68K) on Nov 17, 2025.
Bouek Kirill bought 200 (~$3.13K) on Aug 28, 2025.
Barrios Raymond bought 2.23K (~$34.86K) on Aug 25, 2025.
Barrios Raymond bought 1.01K (~$15.85K) on Aug 25, 2025.

Latest CCAP News

Crescent Capital Cuts Management Fee to 1%, Declares $0.34 Regular and $0.09 Special Dividends — May 13, 2026
Crescent Capital BDC posts 107% dividend coverage, NAV dips to $19.10 — Feb 26, 2026

CCAP Analyst Consensus

5 analysts cover CCAP: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.30.

Common questions about CCAP

Who is trading CCAP stock inside the company?: Recent CCAP insider activity includes Strandberg Steven F. bought 85.00K, Lombard Gerhard bought 2.00K, Bouek Kirill bought 200, Barrios Raymond bought 2.23K, and Barrios Raymond bought 1.01K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CCAP?: Yes. Rallies tracks CCAP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CCAP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CCAP. It does not provide personalized investment advice.